Article info
Response
Payment of COVID-19 challenge trials: underpayment is a bigger worry than overpayment
- Correspondence to Dr Jennifer Blumenthal-Barby, Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX 77030, USA; Jennifer.blumenthal-barby{at}bcm.edu
Citation
Payment of COVID-19 challenge trials: underpayment is a bigger worry than overpayment
Publication history
- Received September 14, 2020
- Accepted October 1, 2020
- First published October 12, 2020.
Online issue publication
January 10, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- Exploring the ethics of tuberculosis human challenge models
- Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
- Uncertainty, error and informed consent to challenge trials of COVID-19 vaccines: response to Steel et al
- Research ethics and public trust in vaccines: the case of COVID-19 challenge trials
- COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement
- Science, politics, ethics and the pandemic
- Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia
- Good reasons to vaccinate: mandatory or payment for risk?
- Payment in challenge studies: ethics, attitudes and a new payment for risk model
- Better recognition for research participants: what society should learn from covid-19